Clinical Trial Update: Radioembolization of Primary and Secondary Liver Malignancies and The Effect On The Immune System [NA]

View source ↗

Summary

A terminated clinical trial evaluating radioembolization for hepatocellular carcinoma and secondary liver malignancies and its effects on the immune system.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Malignant Neoplasm of the Liver

Snippet

Sponsor: University of Minnesota | Conditions: Hepatocellular Carcinoma, Secondary Malignant Neoplasm of Liver | NA | Status: TERMINATED